NetworkNewsBreaks – BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Closes Public Offering Resulting in $60M Gross Proceeds

April 25, 2019 11:27:23

BioDelivery Sciences International (NASDAQ: BDSI) has closed an underwritten public offering of 12,000,000 common stock shares. According to the update, BioDelivery Sciences and a selling stockholder sold the shares at a public offering price of $5.00 per share, resulting in $60 million in gross proceeds. BDSI will not receive any of the proceeds from sale of the common stock shares by the selling stockholder. In addition, underwriters have a 30-day option to purchase up to an additional 1,800,000 common stock shares at the public offering price from a selling stockholder. ROTH Capital Partners acted as co-manager for the transactions.

To view the full press release, visit

About BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology, to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs, including its products BELBUCA® and Symproic®. BDSI’s marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, opioid dependence and opioid induced constipation. For more information, visit the company’s website at

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office